APA (7th ed.) Citation

Darwanto, A., Hein, A., Strauss, S., Kong, Y., Sheridan, A., Richards, D., . . . Te Kaat, K. (2017). Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform. BMC Cancer, 17, 1. https://doi.org/10.1186/s12885-017-3328-z

Chicago Style (17th ed.) Citation

Darwanto, Agus, et al. "Use of the QIAGEN GeneReader NGS System for Detection of KRAS Mutations, Validated by the QIAGEN Therascreen PCR Kit and Alternative NGS Platform." BMC Cancer 17 (2017): 1. https://doi.org/10.1186/s12885-017-3328-z.

MLA (9th ed.) Citation

Darwanto, Agus, et al. "Use of the QIAGEN GeneReader NGS System for Detection of KRAS Mutations, Validated by the QIAGEN Therascreen PCR Kit and Alternative NGS Platform." BMC Cancer, vol. 17, 2017, p. 1, https://doi.org/10.1186/s12885-017-3328-z.